Kartik Anand, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Crispr therapeutics
    Date added:
    03/17/2024
    Date updated:
    03/23/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Eli Lilly
    Date added:
    03/17/2024
    Date updated:
    03/23/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Biotheranostics, Inc
    Topic:
    Advisory Board
    Date added:
    03/17/2024
    Date updated:
    03/23/2025
    Relationship end date:
    06/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Grail
    Date added:
    03/23/2025
    Date updated:
    03/23/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Date added:
    03/23/2025
    Date updated:
    03/23/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novocure
    Date added:
    03/23/2025
    Date updated:
    03/23/2025
Return to Best of ASCO 2025, Omaha